Nerve growth factor antibody and process
AssigneeMassachusetts General Hospital
InventorDavid M. Young
Life of this patent
Estimating the term…
Abstract
An antibody is prepared from a stable new form of nerve growth factor having a molecular weight of about 116,000. The pure nerve growth factor is obtained from an extract of mouse submandibular gland or mouse saliva which is subjected to ion-exchange chromatography to recover a component of the gland or saliva rich in the nerve growth factor and containing proteinaceous material which does not degrade the nerve growth factor. The component rich in nerve growth factor is subjected to at least one additional chromatography step, usually two to four, to obtain pure nerve growth factor. The pure nerve growth factor then is injected into the blood system of an animal to form the antibody which is recovered from the animal's blood serum.
Claims5
A composition having the property of inhibiting the plasminogen activator activity of nerve growth factor having a molecular weight of about 116,000 and being derived from a source selected from the group consisting of mouse submandibular gland, mouse saliva and mixtures thereof, said composition comprising the antibody of said nerve growth factor and being isolated from the blood serum of an animal to which said nerve growth factor has been previously added.
Dependencies are inferred from the claim text.